192 related articles for article (PubMed ID: 33507341)
41. An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia.
Geron I; Savino AM; Fishman H; Tal N; Brown J; Turati VA; James C; Sarno J; Hameiri-Grossman M; Lee YN; Rein A; Maniriho H; Birger Y; Zemlyansky A; Muler I; Davis KL; Marcu-Malina V; Mattson N; Parnas O; Wagener R; Fischer U; Barata JT; Jamieson CHM; Müschen M; Chen CW; Borkhardt A; Kirsch IR; Nagler A; Enver T; Izraeli S
Nat Commun; 2022 Feb; 13(1):659. PubMed ID: 35115489
[TBL] [Abstract][Full Text] [Related]
42. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan.
Sakaguchi K; Imamura T; Ishimaru S; Imai C; Shimonodan H; Fujita N; Okada K; Taketani T; Kanai R; Tauchi H; Kato M; Kojima Y; Watanabe A; Deguchi T; Hashii Y; Kiyokawa N; Taki T; Saito AM; Horibe K; Manabe A; Sato A; Koh K
Pediatr Blood Cancer; 2020 Jul; 67(7):e28341. PubMed ID: 32323914
[TBL] [Abstract][Full Text] [Related]
43. Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Kroeze E; Iaccarino I; Kleisman MM; Mondal M; Beder T; Khouja M; Höppner MP; Scheijde-Vermeulen MA; Kester LA; Brüggemann M; Baldus CD; Cario G; Bladergroen RS; Garnier N; Attarbaschi A; Verdu-Amorós J; Sutton R; Macintyre EA; Scholten K; Arias Padilla L; Burkhardt B; Beishuizen A; den Boer ML; Kuiper RP; Loeffen JLC; Boer JM; Klapper W
Blood; 2024 Apr; ():. PubMed ID: 38588489
[TBL] [Abstract][Full Text] [Related]
44. CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergy.
D'Amico G; Vulcano M; Bugarin C; Bianchi G; Pirovano G; Bonamino M; Marin V; Allavena P; Biagi E; Biondi A
Blood; 2004 Aug; 104(3):744-51. PubMed ID: 15001471
[TBL] [Abstract][Full Text] [Related]
45. A robust in vivo model for B cell precursor acute lymphoblastic leukemia.
Fry TJ; Aplan PD
J Clin Invest; 2015 Sep; 125(9):3427-9. PubMed ID: 26301807
[TBL] [Abstract][Full Text] [Related]
46. CD40 ligand upregulates expression of the IL-3 receptor and stimulates proliferation of B-lineage acute lymphoblastic leukemia cells in the presence of IL-3.
Zhou M; Gu L; Holden J; Yeager AM; Findley HW
Leukemia; 2000 Mar; 14(3):403-11. PubMed ID: 10720134
[TBL] [Abstract][Full Text] [Related]
47. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
[TBL] [Abstract][Full Text] [Related]
48. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
Pérez-Durán P; de Yebenes VG; Ramiro AR
Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
[TBL] [Abstract][Full Text] [Related]
49. HSP90 inhibitors decrease AID levels and activity in mice and in human cells.
Montamat-Sicotte D; Litzler LC; Abreu C; Safavi S; Zahn A; Orthwein A; Müschen M; Oppezzo P; Muñoz DP; Di Noia JM
Eur J Immunol; 2015 Aug; 45(8):2365-76. PubMed ID: 25912253
[TBL] [Abstract][Full Text] [Related]
50. RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.
Jerchel IS; Hoogkamer AQ; Ariës IM; Steeghs EMP; Boer JM; Besselink NJM; Boeree A; van de Ven C; de Groot-Kruseman HA; de Haas V; Horstmann MA; Escherich G; Zwaan CM; Cuppen E; Koudijs MJ; Pieters R; den Boer ML
Leukemia; 2018 Apr; 32(4):931-940. PubMed ID: 28972594
[TBL] [Abstract][Full Text] [Related]
51. Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-kappaB.
Gourzi P; Leonova T; Papavasiliou FN
J Exp Med; 2007 Feb; 204(2):259-65. PubMed ID: 17242162
[TBL] [Abstract][Full Text] [Related]
52. AIDing cancer treatment: Reducing AID activity via HSP90 inhibition.
Rebhandl S; Geisberger R
Eur J Immunol; 2015 Aug; 45(8):2208-11. PubMed ID: 26151367
[TBL] [Abstract][Full Text] [Related]
53. Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells.
Ashley DM; Bol SJ; Kannourakis G
Leuk Res; 1995 Feb; 19(2):113-20. PubMed ID: 7869739
[TBL] [Abstract][Full Text] [Related]
54. T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cells.
Jover JA; Chartash EK; Kushner B; Friedman SM; Crow MK
Clin Immunol Immunopathol; 1989 Oct; 53(1):99-112. PubMed ID: 2527658
[TBL] [Abstract][Full Text] [Related]
55. Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint.
Cantaert T; Schickel JN; Bannock JM; Ng YS; Massad C; Delmotte FR; Yamakawa N; Glauzy S; Chamberlain N; Kinnunen T; Menard L; Lavoie A; Walter JE; Notarangelo LD; Bruneau J; Al-Herz W; Kilic SS; Ochs HD; Cunningham-Rundles C; van der Burg M; Kuijpers TW; Kracker S; Kaneko H; Sekinaka Y; Nonoyama S; Durandy A; Meffre E
J Clin Invest; 2016 Nov; 126(11):4289-4302. PubMed ID: 27701145
[TBL] [Abstract][Full Text] [Related]
56. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.
Norén-Nyström U; Heyman M; Frisk P; Golovleva I; Sundström C; Porwit A; Roos G; Bergh A; Forestier E
Br J Haematol; 2009 Sep; 146(5):521-30. PubMed ID: 19594745
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia.
Swaminathan S; Klemm L; Park E; Papaemmanuil E; Ford A; Kweon SM; Trageser D; Hasselfeld B; Henke N; Mooster J; Geng H; Schwarz K; Kogan SC; Casellas R; Schatz DG; Lieber MR; Greaves MF; Müschen M
Nat Immunol; 2015 Jul; 16(7):766-774. PubMed ID: 25985233
[TBL] [Abstract][Full Text] [Related]
58. Adherence of normal and neoplastic human B cell precursors to the bone marrow microenvironment.
Ryan DH
Blood Cells; 1993; 19(2):225-41; discussion 241-4. PubMed ID: 7906154
[TBL] [Abstract][Full Text] [Related]
59. Flow cytometric analysis of intercellular adhesion between B-cell precursor acute lymphoblastic leukemic cells and bone marrow stromal cells.
Ashley DM; Bol SJ; Tucker DP; Waugh CM; Kannourakis G
Leukemia; 1995 Jan; 9(1):58-67. PubMed ID: 7845030
[TBL] [Abstract][Full Text] [Related]
60. Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells.
Gaipa G; Basso G; Aliprandi S; Migliavacca M; Vallinoto C; Maglia O; Faini A; Veltroni M; Husak D; Schumich A; Ratei R; Biondi A; Dworzak MN;
Cytometry B Clin Cytom; 2008 May; 74(3):150-5. PubMed ID: 18271020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
